Entries of Garbe, Claus on the publication server

Becker, Jürgen C, Ugurel, Selma, Leiter, Ulrike, Meier, Friedegund , Gutzmer, Ralf, Haferkamp, Sebastian, Zimmer, Lisa, Livingstone, Elisabeth, Eigentler, Thomas K , Hauschild, Axel, Kiecker, Felix, Hassel, Jessica C, Mohr, Peter, Fluck, Michael, Thomas, Ioannis , Garzarolli, Marlene, Grimmelmann, Imke, Drexler, Konstantin, Spillner, Alexandra N, Eckhardt, Sebastian, Schadendorf, Dirk, van Akkooi, Alexander, van Houdt, Winan, Wilhelm, Tabea, Farmer, Kimberley, Ulrich, Claas, Gambichler, Thilo, Bluhm, Leonie, Schinagl, Heidemarie, Kellner, Ivonne, Herbst, Rudolf, Meiß, Frank, Rafei-Shamsabadi, David, Sell, Sabine, Kaatz, Martin, Wulfken, Lena, Hartmann, Martin, Kähler, Katharina, Ziemer, Mirjana, Simon, Jan, Terheyden, Patrick, Thaci, Diamant, Loquai, Carmen, Mitzel-Rink, Heidrun, Grabbe, Stephan, Stege, Henner, Gaiser, Maria, Utikal, Jochen, Berking, Carola, Heinzerling, Lucie, Schlaak, Max, Tomsitz, Dirk, Dyballa, Jörg, Magnolo, Nina, Weishaupt, Carsten, Berneburg, Mark, Garbe, Claus, Flatz, Lukas, Gesierich, Anja and Schilling, Bastian (2023) Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial. The Lancet 402 (10404), pp. 798-808. Fulltext not available.

Meyer, Stefanie, Buser, Lorenz , Haferkamp, Sebastian, Berneburg, Mark, Maisch, Tim, Klinkhammer-Schalke, Monika, Pauer, Armin, Vogt, Thomas and Garbe, Claus (2023) Identification of high-risk patients with a seven-biomarker prognostic signature for adjuvant treatment trial recruitment in American Joint Committee on Cancer v8 stage I–IIA cutaneous melanoma. European Journal of Cancer 182, pp. 77-86. Fulltext not available.

Livingstone, Elisabeth, Zimmer, Lisa, Hassel, Jessica C., Fluck, Michael, Eigentler, Thomas K., Loquai, Carmen, Haferkamp, Sebastian , Gutzmer, Ralf, Meier, Friedegund , Mohr, Peter, Hauschild, Axel, Schilling, Bastian, Menzer, Christian , Kiecker, Felix, Dippel, Edgar, Roesch, Alexander, Ziemer, Mirjana, Conrad, Beate, Körner, Silvia, Windemuth-Kieselbach, Christine, Schwarz, Leonora, Garbe, Claus, Becker, Jürgen C., Schadendorf, Dirk, Livingstone, Elisabeth, Zimmer, Lisa, Hassel, Jessica C., Fluck, Michael, Eigentler, Thomas K., Loquai, Carmen, Haferkamp, Sebastian, Gutzmer, Ralf, Meier, Friedegund, Mohr, Peter, Hauschild, Axel, Schilling, Bastian, Menzer, Christian, Kiecker, Felix, Dippel, Edgar, Roesch, Alexander, Ziemer, Mirjana, Conrad, Beate, Körner, Silvia, Simon, Jan-Christoph, Herbst, Rudolf A., Berking, Carola, Utikal, Jochen, Sell, Sabine, Martens, Uwe M., Terheyden, Patrick, Stadler, Rudolf, Windemuth-Kieselbach, Christine, Schwarz, Leonora, Garbe, Claus, Becker, Jürgen C. and Schadendorf, Dirk (2022) Adjuvant nivolumab plus ipilimumab or nivolumab alone versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): final results of a randomised, double-blind, phase 2 trial. The Lancet 400 (10358), pp. 1117-1129. Fulltext not available.

Zimmer, Lisa, Livingstone, Elisabeth, Hassel, Jessica C., Fluck, Michael, Eigentler, Thomas, Loquai, Carmen, Haferkamp, Sebastian, Gutzmer, Ralf, Meier, Friedegund, Mohr, Peter, Hauschild, Axel, Schilling, Bastian, Menzer, Christian, Kieker, Felix, Dippel, Edgar, Rösch, Alexander, Simon, Jan-Christoph, Conrad, Beate, Körner, Silvia, Windemuth-Kieselbach, Christine, Schwarz, Leonora, Garbe, Claus, Becker, Jürgen C., Schadendorf, Dirk, Berking, Carola, Herbst, Rudolf A., Martens, Uwe M., Sell, Sabine, Stadler, Rudolf, Terheyden, Patrick and Utikal, Jochen (2020) Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): a randomised, double-blind, placebo-controlled, phase 2 trial. The Lancet 395 (10236), pp. 1558-1568. Fulltext not available.

Amaral, Teresa, Kiecker, Felix, Schaefer, Sarah, Stege, Henner, Kaehler, Katharina, Terheyden, Patrick, Gesierich, Anja, Gutzmer, Ralf, Haferkamp, Sebastian, Uttikal, Jochen, Berking, Carola, Rafei-Shamsabadi, David, Reinhardt, Lydia, Meier, Friedegund, Karoglan, Ante, Posch, Christian, Gambichler, Thilo, Pfoehler, Claudia, Thoms, Kai, Tietze, Julia, Debus, Dirk, Herbst, Rudolf, Emmert, Steffen, Loquai, Carmen, Hassel, Jessica C, Meiss, Frank, Tueting, Thomas, Heinrich, Vanessa, Eigentler, Thomas, Garbe, Claus and Zimmer, Lisa (2020) Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG* study in 380 patients. Journal for ImmunoTherapy of Cancer 8 (1), e000333. Fulltext not available.

Leiter, Ulrike, Loquai, Carmen, Reinhardt, Lydia, Rafei-Shamsabadi, David , Gutzmer, Ralf, Kaehler, Katharina, Heinzerling, Lucie, Hassel, Jessica C, Glutsch, Valerie, Sirokay, Judith, Schlecht, Nora, Rübben, Albert, Gambichler, Thilo, Schatton, Kerstin, Pfoehler, Claudia, Franklin, Cindy, Terheyden, Patrick, Haferkamp, Sebastian, Mohr, Peter, Bischof, Lena, Livingstone, Elisabeth, Zimmer, Lisa, Weichenthal, Michael, Schadendorf, Dirk, Meiwes, Andreas, Keim, Ulrike, Garbe, Claus, Becker, Jürgen Christian and Ugurel, Selma (2020) Immune checkpoint inhibition therapy for advanced skin cancer in patients with concomitant hematological malignancy: a retrospective multicenter DeCOG study of 84 patients. Journal for ImmunoTherapy of Cancer 8 (2), e000897. Fulltext not available.

Leiter, Ulrike, Heppt, Markus V., Steeb, Theresa, Amaral, Teresa, Bauer, Andrea, Becker, Jürgen C., Breitbart, Eckhardt, Breuninger, Helmut, Diepgen, Thomas, Dirschka, Thomas, Eigentler, Thomas, Flaig, Michael, Follmann, Markus, Fritz, Klaus, Greinert, Rüdiger, Gutzmer, Ralf, Hillen, Uwe, Ihrler, Stephan, John, Swen Malte, Kölbl, Oliver, Kraywinkel, Klaus, Löser, Christoph, Nashan, Dorothee, Noor, Seema, Nothacker, Monika, Pfannenberg, Christina, Salavastru, Carmen, Schmitz, Lutz, Stockfleth, Eggert, Szeimies, Rolf‐Markus, Ulrich, Claas, Welzel, Julia, Wermker, Kai, Garbe, Claus and Berking, Carola (2020) S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma (cSCC) – short version, part 2: epidemiology, surgical and systemic treatment of cSCC, follow‐up, prevention and occupational disease. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 18 (4), pp. 400-413. Fulltext not available.

Heppt, Markus V., Leiter, Ulrike, Steeb, Theresa, Amaral, Teresa, Bauer, Andrea, Becker, Jürgen C., Breitbart, Eckhard, Breuninger, Helmut, Diepgen, Thomas, Dirschka, Thomas, Eigentler, Thomas, Flaig, Michael, Follmann, Markus, Fritz, Klaus, Greinert, Rüdiger, Gutzmer, Ralf, Hillen, Uwe, Ihrler, Stephan, John, Swen Malte, Kölbl, Oliver, Kraywinkel, Klaus, Löser, Christoph, Nashan, Dorothée, Noor, Seema, Nothacker, Monika, Pfannenberg, Christina, Salavastru, Carmen, Schmitz, Lutz, Stockfleth, Eggert, Szeimies, Rolf‐Markus, Ulrich, Claas, Welzel, Julia, Wermker, Kai, Berking, Carola and Garbe, Claus (2020) S3‐Leitlinie „Aktinische Keratose und Plattenepithelkarzinom der Haut“ – Kurzfassung, Teil 1: Diagnostik, Interventionen bei aktinischen Keratosen, Versorgungsstrukturen und Qualitätsindikatoren. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 18 (3), pp. 275-294. Fulltext not available.

Leiter, Ulrike, Heppt, Markus V., Steeb, Theresa, Amaral, Teresa, Bauer, Andrea, Becker, Jürgen C., Breitbart, Eckhardt, Breuninger, Helmut, Diepgen, Thomas, Dirschka, Thomas, Eigentler, Thomas, Flaig, Michael, Follmann, Markus, Fritz, Klaus, Greinert, Rüdiger, Gutzmer, Ralf, Hillen, Uwe, Ihrler, Stephan, John, Swen Malte, Kölbl, Oliver, Kraywinkel, Klaus, Löser, Christoph, Nashan, Dorothee, Noor, Seema, Nothacker, Monika, Pfannenberg, Christina, Salavastru, Carmen, Schmitz, Lutz, Stockfleth, Eggert, Szeimies, Rolf‐Markus, Ulrich, Claas, Welzel, Julia, Wermker, Kai, Garbe, Claus and Berking, Carola (2020) S3‐Leitlinie „Aktinische Keratose und Plattenepithelkarzinom der Haut“ – Kurzfassung, Teil 2: Epidemiologie, chirurgische und systemische Therapie des Plattenepithelkarzinoms, Nachsorge, Prävention und Berufskrankheit. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 18 (4), pp. 400-413. Fulltext not available.

Kreft, Sophia, Gesierich, Anja, Eigentler, Thomas, Franklin, Cindy, Valpione, Sara, Ugurel, Selma, Utikal, Jochen, Haferkamp, Sebastian, Blank, Christian, Larkin, James , Garbe, Claus , Schadendorf, Dirk, Lorigan, Paul and Schilling, Bastian (2019) Efficacy of PD-1–based immunotherapy after radiologic progression on targeted therapy in stage IV melanoma. European Journal of Cancer 116, pp. 207-215. Fulltext not available.

Ulmer, Anja, Dietz, Klaus , Werner-Klein, Melanie, Häfner, Hans-Martin, Schulz, Claudia, Renner, Philipp, Weber, Florian, Breuninger, Helmut, Röcken, Martin, Garbe, Claus , Fierlbeck, Gerhard and Klein, Christoph A. (2018) The sentinel lymph node spread determines quantitatively melanoma seeding to non-sentinel lymph nodes and survival. European Journal of Cancer 91, pp. 1-10. Fulltext not available.

Offenmueller, Sonja, Leiter, Ulrike , Bernbeck, Benedikt, Garbe, Claus, Eigentler, Thomas, Borkhardt, Arndt, Classen, Carl Friedrich, Corbacioglu, Selim, Dirksen, Uta, Ebetsberger-Dachs, Georg, Heinzerling, Lucie, Jorch, Norbert, Kuhlen, Michaela, Lawlor, Jennifer, Niggli, Felix, Streiter, Monika, Schneider, Dominik T. and Brecht, Ines (2017) Clinical characteristics and outcome of 60 pediatric patients with malignant melanoma registered with the German Pediatric Rare Tumor Registry (STEP). Klinische Pädiatrie 229 (06), pp. 322-328. Fulltext not available.

Kamenisch, York, Baban, Tarza S.A., Schuller, Winfried, von Thaler, Anna-Katharina, Sinnberg, Tobias, Metzler, Gisela, Bauer, Jürgen, Schittek, Birgit, Garbe, Claus, Rocken, Martin and Berneburg, Mark (2016) UVA-Irradiation Induces Melanoma Invasion via the Enhanced Warburg Effect. Journal of Investigative Dermatology 136 (9), pp. 1866-1875. Fulltext not available.

Eigentler, Thomas , Assi, Zeinab, Hassel, Jessica C., Heinzerling, Lucie, Starz, Hans, Berneburg, Mark, Bauer, Jürgen and Garbe, Claus (2016) Which melanoma patient carries a BRAF-mutation? A comparison of predictive models. Oncotarget 7 (24). Fulltext not available.

Ulmer, Anja, Dietz, Klaus , Hodak, Isabelle, Polzer, Bernhard, Scheitler, Sebastian, Yildiz, Murat, Czyz, Zbigniew, Lehnert, Petra, Fehm, Tanja, Hafner, Christian, Schanz, Stefan, Röcken, Martin, Garbe, Claus, Breuning, Helmut, Fierlbeck, Gerhard and Klein, Christoph A. (2014) Quantitative Measurement of Melanoma Spread in Sentinel Lymph Nodes and Survival. PLoS ONE 11 (2), e001604.

Eigentler, Thomas K. , Gutzmer, Ralf, Hauschild, Axel, Kämpgen, Eckhart, Schadendorf, Dirk, Nashan, Dorothee, Hölzle, Erhard, Trefzer, Uwe, Becker, Jürgen C., Sunderkötter, Cord, Moll, Ingrid, Richtig, Erika, Pönitzsch, Iris, Pehamberger, Hubert, Kaufmann, Roland, Pfoehler, Claudia, Vogt, Thomas, Berking, Carola, Praxmarer, Michael and Garbe, Claus (2014) Adjuvant therapy with pegylated interferon alfa-2a (PEG-IFN) versus low-dose interferon alfa-2a (IFN) in patients with malignant melanoma in stages IIa(T3a): IIIb (AJCC 2002)—Decog-trial. Journal of Clinical Oncology 32 (15_sup), p. 9071. Fulltext not available.

Grob, Jean Jacques, Jouary, Thomas, Dréno, Brigitte, Asselineau, Julien, Gutzmer, Ralf, Hauschild, Axel, Leccia, Marie Thérèse, Landthaler, Michael, Garbe, Claus, Sassolas, Bruno, Herbst, Rudolf A, Guillot, Bernard, Chene, Genevieve and Pehamberger, Hubert (2013) Adjuvant therapy with pegylated interferon alfa-2b (36 months) versus low-dose interferon alfa-2b (18 months) in melanoma patients without macrometastatic nodes: An open-label, randomised, phase 3 European Association for Dermato-Oncology (EADO) study. European Journal of Cancer 49 (1), pp. 166-174. Fulltext not available.

Pflugfelder, Annette, Kochs, Corinna, Blum, Andreas, Capellaro, Marcus, Czeschik, Christina , Dettenborn, Therese, Dill, Dorothee, Dippel, Edgar, Eigentler, Thomas , Feyer, Petra, Follmann, Markus, Frerich, Bernhard, Ganten, Maria‐Katharina, Gärtner, Jan , Gutzmer, Ralf, Hassel, Jessica, Hauschild, Axel, Hohenberger, Peter, Hübner, Jutta, Kaatz, Martin, Kleeberg, Ulrich R., Kölbl, Oliver, Kortmann, Rolf‐Dieter, Krause‐Bergmann, Albrecht, Kurschat, Peter, Leiter, Ulrike , Link, Hartmut, Loquai, Carmen, Löser, Christoph, Mackensen, Andreas, Meier, Friedegund, Mohr, Peter, Möhrle, Matthias, Nashan, Dorothee, Reske, Sven, Rose, Christian, Sander, Christian, Satzger, Imke, Schiller, Meinhard, Schlemmer, Heinz‐Peter, Strittmatter, Gerhard, Sunderkötter, Cord, Swoboda, Lothar, Trefzer, Uwe, Voltz, Raymond, Vordermark, Dirk, Weichenthal, Michael, Werner, Andreas, Wesselmann, Simone, Weyergraf, Ansgar J., Wick, Wolfgang, Garbe, Claus and Schadendorf, Dirk (2013) Malignant Melanoma S3‐Guideline “Diagnosis, Therapy and Follow‐up of Melanoma”. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 11 (s6), pp. 1-116. Fulltext not available.

Pflugfelder, Annette, Kochs, Corinna, Blum, Andreas, Capellaro, Marcus, Czeschik, Christina , Dettenborn, Therese, Dill, Dorothee, Dippel, Edgar, Eigentler, Thomas , Feyer, Petra, Follmann, Markus, Frerich, Bernhard, Ganten, Maria‐Katharina, Gärtner, Jan , Gutzmer, Ralf, Hassel, Jessica, Hauschild, Axel, Hohenberger, Peter, Hübner, Jutta, Kaatz, Martin, Kleeberg, Ulrich R., Kölbl, Oliver, Kortmann, Rolf‐Dieter, Krause‐Bergmann, Albrecht, Kurschat, Peter, Leiter, Ulrike, Link, Hartmut, Loquai, Carmen, Löser, Christoph, Mackensen, Andreas, Meier, Friedegund, Mohr, Peter, Möhrle, Matthias, Nashan, Dorothee, Reske, Sven, Rose, Christian, Sander, Christian, Satzger, Imke, Schiller, Meinhard, Schlemmer, Heinz‐Peter, Strittmatter, Gerhard, Sunderkötter, Cord, Swoboda, Lothar, Trefzer, Uwe, Voltz, Raymond, Vordermark, Dirk, Weichenthal, Michael, Werner, Andreas, Wesselmann, Simone, Weyergraf, Ansgar J., Wick, Wolfgang, Garbe, Claus and Schadendorf, Dirk (2013) S3‐Guideline “Diagnosis, therapy and follow‐up of melanoma” – short version. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 11 (6), pp. 563-602. Fulltext not available.

Oettle, Helmut, Hilbig, Andreas, Seufferlein, Thomas, Luger, Thomas, Schmid, Roland, von Wichert, Götz, Endlicher, Esther, Garbe, Claus, Kaehler, Katharina C., Hauschild, Axel, Kiessling, Peter, Schmaus, Susanne, Heinrichs, Hubert and Schlingensiepen, Karl-Hermann (2011) Abstract 5506: Trabedersen (AP 12009) for the treatment of patients with advanced tumors: A phase I/II study. Cancer Research 71 (8_Supp), p. 5506. Fulltext not available.

Eigentler, Thomas K. , Figl, Adina, Krex, Dietmar, Mohr, Peter, Mauch, Cornelia, Rass, Knut, Bostroem, Azize, Heese, Oliver, Koelbl, Oliver, Garbe, Claus and Schadendorf, Dirk (2011) Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma. Cancer 117 (8), pp. 1697-1703. Fulltext not available.

Hauschild, Axel, Weichenthal, Michael, Rass, Knuth, Linse, Ruthild, Berking, Carola, Böttjer, Jörg, Vogt, Thomas, Spieth, Konstanze, Eigentler, Thomas , Brockmeyer, Norbert H., Stein, Annette, Näher, Helmut, Schadendorf, Dirk, Mohr, Peter, Kaatz, Martin, Tronnier, Michael, Hein, Rüdiger, Schuler, Gerold, Egberts, Friederike and Garbe, Claus (2010) Efficacy of Low-Dose Interferon α2a 18 Versus 60 Months of Treatment in Patients With Primary Melanoma of ≥ 1.5 mm Tumor Thickness: Results of a Randomized Phase III DeCOG Trial. Journal of Clinical Oncology 28 (5), pp. 841-846. Fulltext not available.

Hauschild, Axel, Weichenthal, Michael, Rass, Knuth, Linse, Ruthild, Ulrich, Jens, Stadler, Rudolf, Volkenandt, Matthias, Grabbe, Stephan, Proske, Ulrike, Schadendorf, Dirk, Brockmeyer, Norbert, Vogt, Thomas, Rompel, Rainer, Kaufmann, Roland, Kaatz, Martin, Näher, Helmut, Mohr, Peter, Eigentler, Thomas , Livingstone, Elisabeth and Garbe, Claus (2009) Prospective Randomized Multicenter Adjuvant Dermatologic Cooperative Oncology Group Trial of Low-Dose Interferon Alfa-2b With or Without a Modified High-Dose Interferon Alfa-2b Induction Phase in Patients With Lymph Node–Negative Melanoma. Journal of Clinical Oncology 27 (21), pp. 3496-3502. Fulltext not available.

Garbe, Claus, Hauschild, Axel, Volkenandt, Matthias, Schadendorf, Dirk, Stolz, Wilhelm, Reinhold, Uwe, Kortmann, Rolf-Dieter, Kettelhack, Christoph, Frerich, Bernhard, Keilholz, Ulrich, Dummer, Reinhard, Sebastian, Günther, Tilgen, Wolfgang, Schuler, Gerold, Mackensen, Andreas and Kaufmann, Roland (2008) Evidence and interdisciplinary consensus-based German guidelines: surgical treatment and radiotherapy of melanoma. Melanoma Research 18 (1), pp. 61-67. Fulltext not available.

Garbe, Claus, Hauschild, Axel, Volkenandt, Matthias, Schadendorf, Dirk, Stolz, Wilhelm, Reinhold, Uwe, Kortmann, Rolf-Dieter, Kettelhack, Christoph, Frerich, Bernhard, Keilholz, Ulrich, Dummer, Reinhard, Sebastian, Günther, Tilgen, Wolfgang, Schuler, Gerold, Mackensen, Andreas and Kaufmann, Roland (2008) Evidence-based and interdisciplinary consensus-based German guidelines: systemic medical treatment of melanoma in the adjuvant and palliative setting. Melanoma Research 18 (2), pp. 152-160. Fulltext not available.

Breuninger, Helmut, Bootz, Friedrich, Hauschild, Axel, Kortmann, Rolf‐Dieter, Wolff, Klaus, Stockfleth, Eggert, Szeimies, Markus, Rompel, Rainer and Garbe, Claus (2008) Short German guidelines: Squamous cell carcinoma. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 6 (s1). Fulltext not available.

Garbe, Claus, Terheyden, Patrick, Keilholz, Ulrich, Kölbl, Oliver and Hauschild, Axel (2008) Treatment of Melanoma. Deutsches Ärzteblatt international. Fulltext not available.

Garbe, Claus, Hauschild, Axel, Volkenandt, Matthias, Schadendorf, Dirk, Stolz, Wilhelm, Reinhold, Uwe, Kortmann, Rolf-Dieter, Kettelhack, Christoph, Frerich, Bernhard, Keilholz, Ulrich, Dummer, Reinhard, Sebastian, Günther, Tilgen, Wolfgang, Schuler, Gerold, Mackensen, Andreas and Kaufmann, Roland (2007) Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma. Melanoma Research 17 (6), pp. 393-399. Fulltext not available.